Buddy Roemer: Me, O...
Technology: Telecommunications
American Tower Corp (AMT: NYSE)
$63.79 -0.06 | -0.09%
02/09/12 - 04:01 PM ET
2.24M / 3.11M
Vol / Avg. Vol:63.91 / 63.85
Open / Prev. Close:63.14 - 64.02
Today's Range:45.85 - 63.85
52 Wk Range:6.40%
Performance YTD:TheStreet Rating:
Portfolios with AMT
- Portfolio NameUser Type
- User2-3-2012
- UserCal Green Stockpickr Watchlist
- ContributorTop-Rated Wireless Stocks
- Contributor5 Telecom Picks for 2012
- ContributorHedge Funds' Best Picks for...
- ProLarry Robbins - Glenview Ca...
- ProViking Global Investors
- ProBruce Kovner - Caxton Assoc...
- Contributor5 Telecom Stocks With Upside
- ProAppaloosa Management
Latest AMT Headlines from TheStreet
- American Tower Reaches New 52-Week High (AMT) 02.09.12 | 01:02 pm
- American Tower Stock Hits New 52-Week High (AMT) 01.25.12 | 12:01 pm
- 'Mad Money Lightning Round': Go for American Tower 01.20.12 | 07:01 pm
- Cramer's 'Mad Money' Recap: Next Week's Game Plan (Final) 01.20.12 | 06:01 pm
- American Tower Reaches New 52-Week High (AMT) 01.10.12 | 10:01 am
- AT&T Deal Bust Could Force Cell Tower Land Rush 12.20.11 | 04:12 pm
- American Tower Reaches New 52-Week High (AMT) 12.20.11 | 01:12 pm
- 'Fast Money' Recap: Winners on AT&T's Dead Deal 12.19.11 | 06:12 pm
- American Tower Corp (AMT): Today's Featured Telecommunications Winner 12.15.11 | 04:12 pm
- 5 Telecom Picks for 2012 12.12.11 | 10:12 am
Press Releases for AMT
- American Tower Corporation Completes New Revolving Credit Facility - Business Wire 01.31.12 | 05:01 pm
- American Tower Corporation Announces 2012 Annual Meeting Date - Business Wire 01.31.12 | 05:01 pm
- Amsterdam Molecular Therapeutics Announces European Commission Delays Decision On Glybera® Marketing Authorisation And Requests Further Information From The CHMP - PR Newswire 01.30.12 | 01:01 am
- S&P Capital IQ Picks American Tower Corp. Focus Stock Of The Week - PR Newswire 01.09.12 | 01:01 pm
- American Tower Plans Fourth Quarter And Full Year 2011 Earnings Release And Conference Call - Business Wire 01.09.12 | 08:01 am
- Amsterdam Molecular Therapeutics Receives US Orphan Designation For Hemophilia B Gene Therapy - PR Newswire 01.04.12 | 01:01 am
- American Tower Corporation Completes Merger And Commences Operations As A REIT - Business Wire 01.03.12 | 08:01 am
- Amsterdam Molecular Therapeutics Announces ¬ 2.5 Million Equity Raise - PR Newswire 12.30.11 | 01:12 am
- American Tower Corporation To Deliver Keynote At The Citigroup Entertainment, Media And Telecommunications Conference - Business Wire 12.22.11 | 05:12 pm
- Amsterdam Molecular Therapeutics Announces Negative Equity Position - PR Newswire 12.15.11 | 01:12 am
Partner Headlines for AMT
- Crown Castle Beats in 4Q - Analyst Blog - Zacks 01.30.12 | 09:01 am
- Cramer's Lightning Round - American Tower Is A Smoking Good Company (1/20/12) - Seeking Alpha 01.22.12 | 07:01 am
- Andreas Halvorsen's Top 10 Positions Returned 28% Since September - Seeking Alpha 01.15.12 | 07:01 am
- Crown Castle Expands Asset Portfolio - Analyst Blog - Zacks 01.13.12 | 05:01 pm
- MTN Group: A High-Quality Play On Africa's Potential - Seeking Alpha 01.10.12 | 08:01 am
- UPDATE: J.P. Morgan Downgrades American Tower to Neutral - Benzinga 01.03.12 | 09:01 am
- Rating Agencies Revise CCI Outlook - Analyst Blog - Zacks 12.21.11 | 09:12 am
- Crown Castle Solidifies DAS Network - Analyst Blog - Zacks 12.20.11 | 09:12 am
- Zacks Bull and Bear of the Day Highlights: DENTSPLY International, Linear Technology, Citigroup, Bank of America and American Tower - Press Releases - Zacks 12.01.11 | 09:12 am
- Good News from China, Jobs - Analyst Blog - Zacks 11.30.11 | 10:11 am
